1700657-83-5: Tacrolimus Hydroxy Acid Impurity

1700657-83-5: Tacrolimus Hydroxy Acid Impurity

Tacrolimus Hydroxy Acid Impurity (CAS No: 1700657-83-5) Or (3S,4R,5S,8R,12S,14S,16S,18R,25aS,E)-8-allyl-5,15,19-trihydroxy-3-((E)-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-1,7,20-trioxo-1,3,4,5,6,7,8,11,12,13,14,15,16,17,18,19,20,22,23,24,25,25a-docosahydropyrido[2,1-c]1oxa4azacyclodocosine-19-carboxylic acid,Tacrolimus Hydroxy Acidy is an impurity of Tacrolimus,Tacrolimus is macrolide drug, which is widely used as a potent immunosuppr

Additional information on CAS 1700657-83-5

Catalogue No.

VE000122
CAS No.

1700657-83-5
Molecular Formula

C44H71NO13
Molecular Weight

822.05 g/mol
Parent drug

Tacrolimus
IUPAC Name

(3S, 4R, 5S, 8R, 12S, 14S, 16S, 18R, 25aS, E)-8-allyl-5, 15, 19-trihydroxy-3-((E)-1-((1R, 3R, 4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14, 16-dimethoxy-4, 10, 12, 18-tetramethyl-1, 7, 20-trioxo-1, 3, 4, 5, 6, 7, 8, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 22, 23, 24, 25, 25a-docosahydropyrido[2, 1-c][1]oxa[4]azacyclodocosine-19-carboxylic acid
Synonyms

N/A
References

Sci-Hub, Solid state compatibility study and characterization of a novel degradation product of tacrolimus in formulation, 10.1016/j.jpba.2015.02.047. (2015). Retrieved January 23, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/j.jpba.2015.02.047
Status

In-stock

Other products related to tacrolimus